Secondly, RPL22 has been identified as a potential tumor suppressor gene that is mutated or deleted in T‐ALL and several epithelial tumor types (Rao et al, 2012; Novetsky et al, 2013; Goudarzi & Lindstrom, 2016). This evidence concerns the gene RPL22 and neoplasm.